| Abstrakt: |
11,1 2-Epoxyeicosatrienoic acid (11,12-EET), a potent vasodilator produced by the endothelium, acts on calcium-activated potassium channels and shares biological activities with the heme oxygenase/ carbon monoxide (HO/CO) system. We examined whether activation of HO mediates the dilator action of 11,1 2-EET, and that of the other EETs, on rat mesenteric arteries. Dose-response curves (10-9 to 10-6 M) to 5,6-EET, 8,9-EET, 11,12-EET, 14,15-EET, and ACh (10-9 to 10-4 M) were evaluated in preconstricted (10-6 mol/l phenylephrine) mesenteric arteries (< 350 µm diameter) in the presence or absence of 2) the cyclooxygenase inhibitor indomethacin (2.8 µM), 2) the HO inhibitor chromium mesoporphyrin (CrMP) (15 µM), 3) the soluble guanylyl cyclase (GC) inhibitor ODQ (10 µM), and 4) the calcium-activated potassium channel inhibitor iberiotoxin (25 nM). The vasodilator response to 11,12-EET was abolished by CrMP and iberiotoxin, whereas indomethacin and ODQ had no effect. In contrast, the effect of ACh was attenuated by ODQ but not by CrMP. The vasodilator effect of 8,9-EET, like that of 1 l,12-EET, was greatly attenuated by HO inhibition. In contrast, the mesenteric vasodilator response to 5,6-EET was independent of both HO and GC, whereas that to 14,15-EET demonstrated two components, an HO and a OC, of equal magnitude. Incubation of mesenteric microvessels with 11,12-EET caused a 30% increase in CO release, an effect abolished by inhibition of HO. We conclude that the rat mesenteric vasodilator action of 1 l,12-EET is mediated via an increase in HO activity and an activation of calcium-activated potassium channels. [ABSTRACT FROM AUTHOR] |
